about
The APJ receptor: a new therapeutic approach in diabetic treatmentApelin stimulates glucose utilization in normal and obese insulin-resistant miceLRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue.Cathepsin-D, a key protease in breast cancer, is up-regulated in obese mouse and human adipose tissue, and controls adipogenesisApelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice.The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease.The use of urinary proteomics in the assessment of suitability of mouse models for ageing.Periprostatic adipocytes act as a driving force for prostate cancer progression in obesityTriggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia.Expanding role for the apelin/APJ system in physiopathology.Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.Apelin, diabetes, and obesity.Apelin, a promising target for type 2 diabetes treatment?Incorporation of fungal cellulases in bacterial minicellulosomes yields viable, synergistically acting cellulolytic complexes.Apelin receptors: From signaling to antidiabetic strategy.Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp.Simultaneous quantitative profiling of 20 isoprostanoids from omega-3 and omega-6 polyunsaturated fatty acids by LC-MS/MS in various biological samples.TNFalpha up-regulates apelin expression in human and mouse adipose tissue.Native fructose extracted from apple improves glucose tolerance in mice.Lipopolysaccharides-mediated increase in glucose-stimulated insulin secretion: involvement of the GLP-1 pathway.Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.Cognitive deficit in hippocampal-dependent tasks in Werner syndrome mouse model.Aeroaging - A New Collaboration between Life Sciences Experts and Aerospace Engineers.Collective and experimental research project for master's students on the pathophysiology of obesity.Interrelationship between lymphocytes and leptin in fat depots of obese mice revealed by changes in nutritional status.Apelin: an antithrombotic factor that inhibits platelet function.Isoprostanes as markers for muscle aging in older athletes.The exerkine apelin reverses age-associated sarcopeniaThe intestinal glucose-apelin cycle controls carbohydrate absorption in miceResponse to Elia et al. 'Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis'Diet-induced obesity and associated disorders are prevented by natural bioactive type 1 fish collagen peptides (Naticol®) treatmentApelin affects the mouse aging urinary peptidome with minimal effects on kidneyHighlights from the 2019 International Congress on Frailty and Sarcopenia Research
P50
Q27025069-81A56BE4-D8F5-4245-BDA2-AF3A1116EB4DQ28302298-57101353-676C-4840-B48E-E4F63AF5F212Q33510159-FA1BBF72-D0B9-4C1F-A238-3B353678C079Q33818227-617C232A-1C9C-4348-8EB9-DA6771B3C5E5Q34030044-8D9F0A34-6944-4FFE-ACB7-06DA0A70C1D4Q35685817-BB2F2BB8-71BA-4C9C-830B-2AAD0428EDB5Q36281053-5256D0C6-657D-41E1-9A08-0EA20F3DE20DQ36511320-8FC0B8C0-994B-43B4-A65E-E6AAC9D2A89FQ36928736-5035A314-C611-4644-B343-27812C781220Q37154640-D3AD31AA-6BD7-498D-9629-6D8A3D905EA2Q37194593-67E8FA74-6AE5-4C6F-BC9C-E695FB2D850BQ37897155-482CA6C0-66FC-4022-87C1-969444B6EC2EQ37996726-26E49F62-C3DF-4989-8A8B-BA20ECF305C7Q38302238-0C437B03-8E66-4463-AF8F-22DD091AE098Q38501605-0E51A396-911D-432B-9E0E-811D062814BAQ38691457-EFEA42CC-90D5-4E5E-8AB8-547575EECC36Q41062855-8B0563D5-97C0-43BC-9027-3C3FB29875F3Q42801394-7B83003E-FD42-468F-BA81-B280F7056C3CQ43112494-01735A42-440B-4958-807E-F7CBCD3053F7Q43523674-0BFA6D1C-3522-4F68-B69E-1AD69B0717C3Q46538045-2665B5A5-F4BE-4F54-861D-8E277E2E286CQ47350405-F42B31D2-6892-4AE6-B122-DE6CF2CD0245Q47399158-F41A5D4B-233C-42C9-A835-D87A5B84DB48Q47863906-60008787-C7A3-424D-B307-76B33BDD1E51Q51308061-A7CB8561-B367-4E9B-8A4D-BB241C2D0C80Q53260330-010296CF-202C-4E1E-84DC-374F12C52904Q55024770-470E718A-1497-4538-A563-FE176D611A7FQ56873576-18E0AC10-C5BF-49F2-A91C-95B3EEB330FBQ85892132-21BC4E9F-EE29-4650-AF53-03E0F9F42DD1Q85909836-4A197B28-5C38-42B4-8600-C102F77AFA3BQ91558134-1A168E8B-C750-4F7B-9BC8-7E9B716D2142Q92134529-B4D668AD-3798-4981-9DA5-C288E124A09DQ93009976-A5A79F56-7CA0-46DF-A3E3-364429B574D1
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Cyril Dray
@en
Cyril Dray
@nl
type
label
Cyril Dray
@en
Cyril Dray
@nl
prefLabel
Cyril Dray
@en
Cyril Dray
@nl
P31
P496
0000-0002-4712-791X